FDA recall D-0516-2026

Ajanta Pharma Ltd. · Class II · drug

Product

Duloxetine Delayed-Release Capsules, 20 mg, Rx Only, 60 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-097-06.

Reason for recall

CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.

Distribution

Nationwide within U.S

Key facts

Status
Ongoing
Initiation date
2026-04-29
Report date
2026-05-13
Voluntary/Mandated
Voluntary: Firm initiated
Location
Aurangabad, India

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0516-2026